Cargando…

Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway

We established an orthotopic non-muscle invasive bladder cancer (NMIBC) mouse model expressing the mammalian target of the rapamycin (mTOR) signaling pathway. After intravesical instillation of KU-7-lucs (day 0), animals were subsequently monitored by bioluminescence imaging (BLI) on days 4, 7, 14,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Soon-Ja, Seo, Ho Kyung, Seo, Hye-Hyun, Lee, Sang-Jin, Kwon, Jong Kyou, Lee, Tae-Jin, Chi, Byung Hoon, Chang, In Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945128/ https://www.ncbi.nlm.nih.gov/pubmed/24616582 http://dx.doi.org/10.3346/jkms.2014.29.3.343

Ejemplares similares

Erratum: Correction of Acknowledgement. Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway
por: Kim, Soon-Ja, et al.
Publicado: (2014)

P70S6K and Elf4E Dual Inhibition Is Essential to Control Bladder Tumor Growth and Progression in Orthotopic Mouse Non-muscle Invasive Bladder Tumor Model
por: Chi, Byung Hoon, et al.
Publicado: (2015)

The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression
por: Seo, Ho Kyung, et al.
Publicado: (2016)

Tumor Establishment Features of Orthotopic Murine Bladder Cancer Models
por: Lee, Jin Seok, et al.
Publicado: (2012)

Daily Mean Temperature Affects Urolithiasis Presentation in Seoul: a Time-series Analysis
por: Lee, SeoYeon, et al.
Publicado: (2016)

Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts
por: Jäger, Wolfgang, et al.
Publicado: (2014)

Establishment of an optimized orthotopic bladder cancer model in mice
por: Cai, Jinming, et al.
Publicado: (2022)

Establishment of a Stable Cell Line Expressing Green Fluorescence Protein-fused Hypoxia Inducible Factor-1α for Assessment of Carcinogenicity of Chemical Toxicants
por: Kim, Sung-Hye, et al.
Publicado: (2009)

Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence
por: Kim, Soon-Ja, et al.
Publicado: (2014)

Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence
por: Kim, Soon-Ja, et al.
Publicado: (2014)

A New Method of Establishing Orthotopic Bladder Transplantable Tumor in Mice
por: Yang, Xi-hua, et al.
Publicado: (2012)

Blocking mammalian target of rapamycin alleviates bladder hyperactivity and pain in rats with cystitis
por: Liang, Simin, et al.
Publicado: (2016)

Evaluation of global laboratory methods and establishing on‐therapy ranges for monitoring apixaban and rivaroxaban: Experience at a single institution
por: Park, Soon Ho, et al.
Publicado: (2019)

Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
por: Lee, Hye Won, et al.
Publicado: (2022)

Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic Bladder Urothelial Carcinomas via Dual Targeting of Tumor-Specific Oncogenic Signaling and the Tumor Immune Microenvironment
por: Lee, Hye Won, et al.
Publicado: (2021)

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma
por: Jin, Hong-Guang, et al.
Publicado: (2018)

Effectiveness of Flexible Ureteroscopic Stone Removal for Treating Ureteral and Ipsilateral Renal Stones: A Single-Center Experience
por: Lee, Sang Hyup, et al.
Publicado: (2013)

Where are we now and where are we heading in muscle invasive bladder cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2020)

Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy
por: Huan, Jianya, et al.
Publicado: (2022)

Establishment of linear accelerator-based image guided radiotherapy for orthotopic 4T1 mouse mammary tumor model
por: Lee, Seung-Heon, et al.
Publicado: (2014)

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model
por: Wang, Cun, et al.
Publicado: (2012)

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
por: Querfurth, Henry, et al.
Publicado: (2021)

Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology
por: Choi, Hae Woong, et al.
Publicado: (2021)

Acid-base disorders after orthotopic bladder replacement: comparison of an ileal neobladder and an ileal conduit
por: Cho, AJin, et al.
Publicado: (2017)

Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies
por: Kim, Kyung Hwan, et al.
Publicado: (2023)

Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations
por: Lee, Hye Won, et al.
Publicado: (2023)

Pilot Study of Low-Dose Nonenhanced Computed Tomography With Iterative Reconstruction for Diagnosis of Urinary Stones
por: Park, Sang Ho, et al.
Publicado: (2014)

Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer
por: Hahn, Ho-Suap, et al.
Publicado: (2014)

Structure establishment of three-dimensional (3D) cell culture printing model for bladder cancer
por: Kim, Myeong Joo, et al.
Publicado: (2019)

Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer
por: Kwon, Whi-An, et al.
Publicado: (2020)

Establishment of a Korea HPV cohort study
por: Lee, Won-Chul, et al.
Publicado: (2013)

Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer
por: Kim, SungEun, et al.
Publicado: (2019)

Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel
por: Yoon, Ho Yub, et al.
Publicado: (2019)

Mammalian target of Rapamycin inhibition and mycobacterial survival are uncoupled in murine macrophages
por: Zullo, Alfred J, et al.
Publicado: (2014)

Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08
por: Kim, Ki Hyang, et al.
Publicado: (2016)

Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer
por: Seo, Ho Kyung, et al.
Publicado: (2014)

Mammalian Target of Rapamycin Complex 2 (mTORC2) Is a Critical Determinant of Bladder Cancer Invasion
por: Gupta, Sounak, et al.
Publicado: (2013)

A rapamycin derivative, biolimus, preferentially activates autophagy in vascular smooth muscle cells
por: Kim, Yerin, et al.
Publicado: (2018)

Long-term Mortality in Adult Orthotopic Heart Transplant Recipients
por: Jung, Sung-Ho, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_smll0b3dej719ds8rdo4on4lor